Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: Analysis from the german transcatheter aortic valve interventions registry

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 4, 2013, Pages

  Ledwoch, Jakob ^a   Franke, Jennifer ^a   Gerckens, Ulrich ^b   Kuck, Karl Heinz ^c   Linke, Axel ^d   Nickenig, Georg ^e   Krülls Münch, Jürgen ^f   Vöhringer, Matthias ^g   Hambrecht, Rainer ^h   Erbel, Raimund ⁱ   Richardt, Gert ^j   Horack, Martin ^k   Zahn, Ralf ^l   Senges, Jochen ^k   Sievert, Horst ^a  

^a CARDIOVASCULAR CENTER FRANKFURT   (Germany)

^b Helios Klinikum   (Germany)

^c DEPARTMENT OF CARDIOLOGY   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f Sana Herzzentrum Cottbus   (Germany)

^g ROBERT BOSCH HOSPITAL   (Germany)

^h Klinikum Bremen   (Germany)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j Segeberger Kliniken GmbH   (Germany)

^k Institut fur Herzinfarktforschung   (Germany)

^l KLINIKUM LUDWIGSHAFEN   (Germany)

more..

Author keywords

incidence; permanent pacemaker implantation; predictors; transcatheter aortic valve implantation

Indexed keywords

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; ARTICLE; DISEASE REGISTRY; FEMALE; GERMANY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VALVE SURGERY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTION; PROSPECTIVE STUDY; SURVIVAL TIME; THERAPY EFFECT; TRANSCATHETER AORTIC VALVE IMPLANTATION;

INCIDENCE; PERMANENT PACEMAKER IMPLANTATION; PREDICTORS; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; CARDIAC CATHETERIZATION; CARDIAC PACING, ARTIFICIAL; FEMALE; GERMANY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885019558     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24915     Document Type: Article

References (31)

1. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U,. Progress and current status of percutaneous aortic valve replacement: Results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv 2008; 1: 167-175.
2. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V,. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006; 47: 1214-1223.
3. Baan J Jr, Yong ZY, Koch KT, Henriques JP, Bouma BJ, Vis MM, Cocchieri R, Piek JJ, de Mol BA,. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 2010; 159: 497-503.
4. Erkapic D, Kim WK, Weber M, Mollmann H, Berkowitsch A, Zaltsberg S, Pajitnev DJ, Rixe J, Neumann T, Kuniss M, Sperzel J, Hamm CW, Pitschner HF,. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace 2010; 12: 1188-1190.
5. Roten L, Wenaweser P, Delacretaz E, Hellige G, Stortecky S, Tanner H, Pilgrim T, Kadner A, Eberle B, Zwahlen M, Carrel T, Meier B, Windecker S,. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol 2010; 106: 1473-1480.
6. Elahi M, Usmaan K,. The bioprosthesis type and size influence the postoperative incidence of permanent pacemaker implantation in patients undergoing aortic valve surgery. J Interv Card Electrophysiol 2006; 15: 113-118.
7. Anderson RH, Yanni J, Boyett MR, Chandler NJ, Dobrzynski H,. The anatomy of the cardiac conduction system. Clin Anat 2009; 22: 99-113.
8. Bleiziffer S, Ruge H, Horer J, Hutter A, Geisbusch S, Brockmann G, Mazzitelli D, Bauernschmitt R, Lange R,. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010; 3: 524-530.
9. Roques F, Nashef SA, Michel P,. Risk factors for early mortality after valve surgery in Europe in the 1990s: Lessons from the EuroSCORE pilot program. J Heart Valve Dis 2001; 10: 572-577; discussion 7-8.
10. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J,. Transcatheter aortic valve implantation: First results from a multicentre real-world registry. Eur Heart J 2011; 32: 198-204.
11. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP,. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308.
12. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrie D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M,. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-1715.
13. Jilaihawi H, Chin D, Vasa-Nicotera M, Jeilan M, Spyt T, Ng GA, Bence J, Logtens E, Kovac J,. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 2009; 157: 860-866.
14. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, Brown S, Khan SQ, Walker N, Trivedi U, Hutchinson N, De Belder AJ, Moat N, Blackman DJ, Levy RD, Manoharan G, Roberts D, Khogali SS, Crean P, Brecker SJ, Baumbach A, Mullen M, Laborde JC, Hildick-Smith D,. Permanent pacemaker insertion after corevalve transcatheter aortic valve implantation: Incidence and contributing factors (the UK CoreValve Collaborative). Circulation 2011; 123: 951-960.
15. Gutierrez M, Rodes-Cabau J, Bagur R, Doyle D, DeLarochelliere R, Bergeron S, Lemieux J, Villeneuve J, Cote M, Bertrand OF, Poirier P, Clavel MA, Pibarot P, Dumont E,. Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J 2009; 158: 302-308.
16. Ye J, Cheung A, Lichtenstein SV, Nietlispach F, Albugami S, Masson JB, Thompson CR, Munt B, Moss R, Carere RG, Jamieson WR, Webb JG,. Transapical transcatheter aortic valve implantation: Follow-up to 3 years. J Thorac Cardiovasc Surg 2010; 139: 1107-1113, 13 e1.
17. Calvi V, Puzzangara E, Pruiti GP, Conti S, Di Grazia A, Ussia GP, Capodanno D, Tamburino C,. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol 2009; 32 (Suppl 1): S126-S130.
18. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW,. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
19. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere PP, Serruys PW,. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008; 1: 310-316.
20. Guinot PG, Depoix JP, Etchegoyen L, Benbara A, Provenchere S, Dilly MP, Philip I, Enguerand D, Ibrahim H, Vahanian A, Himbert D, Al-Attar N, Nataf P, Desmonts JM, Montravers P, Longrois D,. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: Analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth 2010; 24: 752-761.
21. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC, Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Riegel B, Tarkington LG, Yancy CW,. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for thoracic surgery and society of thoracic surgeons. J Am Coll Cardiol 2008; 51: e1-e62.
22. Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, Garcia-Garcia H, Schultz C, van Domburg R, van Es GA, van Geuns R, de Jaegere P, Serruys PW,. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 2010; 6: 475-484.
23. Latsios G, Gerckens U, Buellesfeld L, Mueller R, John D, Yuecel S, Syring J, Sauren B, Grube E,. "Device landing zone" calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv 2010; 76: 431-439.
24. D'Ancona G, Pasic M, Unbehaun A, Hetzer R,. Permanent pacemaker implantation after transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg 2011; 13: 373-376.
25. Ferreira ND, Caeiro D, Adao L, Oliveira M, Goncalves H, Ribeiro J, Teixeira M, Albuquerque A, Primo J, Braga P, Simoes L, Ribeiro VG,. Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis. Pacing Clin Electrophysiol 2010; 33: 1364-1372.
26. Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R, Corrado D, Bonato R, Basso C, Thiene G, Gerosa G, Isabella G, Iliceto S, Napodano M,. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 2011; 107: 747-754.
27. Moreno R, Dobarro D, Lopez de Sa E, Prieto M, Morales C, Calvo Orbe L, Moreno-Gomez I, Filgueiras D, Sanchez-Recalde A, Galeote G, Jimenez-Valero S, Lopez-Sendon JL,. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation 2009; 120: e29-e30.
28. Allison MA, Cheung P, Criqui MH, Langer RD, Wright CM,. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation 2006; 113: 861-866.
29. Gordon RS, Ivanov J, Cohen G, Ralph-Edwards AL,. Permanent cardiac pacing after a cardiac operation: Predicting the use of permanent pacemakers. Ann Thorac Surg 1998; 66: 1698-1704.
30. Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Maugenest AM, Cheng J, Piazza N, van Domburg RT, Serruys PW, de Jaegere PP,. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J 2011; 32: 2067-2074.
31. Betts TR,. Regional survey of temporary transvenous pacing procedures and complications. Postgrad Med J 2003; 79: 463-465.